Federal Bid

Last Updated on 13 Jul 2016 at 8 AM
Sources Sought
Location Unknown

Promega Corporation Reagents for Small Molecule and siRNA Screening

Solicitation ID HHS-NIH-NIDA-SSSA-SBSS-16-422
Posted Date 17 Jun 2016 at 1 PM
Archive Date 13 Jul 2016 at 5 AM
NAICS Category
Product Service Code
Set Aside No Set-Aside Used
Contracting Office National Institute On Drug Abuse, Station Support/Simplified Acquisitions
Agency Department Of Health And Human Services
Location United states
Request for Information/Sources Sought Notice
HHS-NIH-NIDA-SSSA-SBSS-16-422

Promega Corporation Reagents for Small Molecule and siRNA Screening

Contracting Office Address:
Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Station Support Simplified Acquisitions, 31 Center Drive, Room 1B59, Bethesda, MD 20892, UNITED STATES.

Introduction:
This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations.

The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified large business and small business sources, (2) whether they small businesses are small businesses; HUBZone small businesses, service-disabled, veteran-owned small businesses; 8(a) small businesses; veteran-owned small businesses; woman-owned small businesses; or small disadvantaged businesses; and (3) large and small business size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible.

Background:
The National Center for Advancing Translational Sciences (NCATS) applies the tools of small molecule screening and discovery to the development of chemical probe research tools for use in the study of protein and cell functions, and biological processes relevant to physiology and disease. Many of the protocols run by the NCATS laboratories utilize Promega Corporation reagents in their ongoing assays and NCATS wishes to consolidate these reagent purchases to maximize efficiency and economies of scale for cost savings.

Purpose and Objectives for the Procurement:
The purpose of this acquisition is procurement of reagent kits for high-throughput screening done throughout the NCAT's various labs. To ensure continuity of science, this is a sole source effort as the screening protocols requiring reagent kits were designed with Promega Corporation reagents.

Project Requirements:
The Contractor shall provide the following Promega Corporation reagents:

Group One - Delivery within 3 months from award date
Item # Quantity Product Description
G8462 20 CellTiter-Glo(R) One Solution Assay, 500ml
G6082 50 CellTiter-Fluor(TM) Cell Viability Assay, 2 x 50ml
G9713 10 RealTime-Glo(TM) MT Cell Viability Assay, 1000 RXN
G8731 10 CellTox(TM) Green Express Cytotoxicity Assay
G9682 3 CellTiter-Glo(R) 3D Cell Viability Assay, 10 x 10ml

Item # Quantity Product Description
G8462 40 CellTiter-Glo(R) One Solution Assay, 500ml
G8092 4 Caspase-Glo(R) 3/7 Assay, 100ml

Item # Quantity Product Description
G8462 30 CellTiter-Glo(R) One Solution Assay, 500ml
E6130 5 ONE-Glo(TM) Luciferase Assay System, 1L

Item # Quantity Product Description
G7573 3 CellTiter-Glo(R) Luminescent Cell Viability, 10 x 100ml
G8232 5 BacTiter-Glo(TM) Microbial Cell Viability Assay, 100ml
V3774 1 Kinase-Glo(R) Plus Luminescent Kinase Assay 10 x 100ml

Item # Quantity Product Description
E6130 2 ONE-Glo(TM) Luciferase Assay System, 1L
E6120 10 ONE-Glo(TM) Luciferase Assay System, 100ml
G8233 3 BacTiter-Glo(TM) Microbial Cell Viability Assay, 10x100ml
G8092 10 Caspase-Glo(R) 3/7 Assay, 100ml
G8462 2 CellTiter-Glo(R) One Solution Assay, 500ml

Item # Quantity Product Description
G7573 1 CellTiter-Glo(R) Luminescent Cell Viability, 10 x 100ml
AX1500 2 Nano-Glo(R) Dual-Luciferase(R) Reporter Assay System, Custom
N1150 1 Nano-Glo(R) Luciferase Assay,10x100ml
G7573 1 CellTiter-Glo(R) Luminescent Cell Viability, 10 x 100ml
AX1500 8 Nano-Glo(R) Dual-Luciferase(R) Reporter Assay System, Custom
G7573 1 CellTiter-Glo(R) Luminescent Cell Viability, 10 x 100ml

Group Two - Delivery within 6 months from award date
Item # Quantity Product Description
G8462 80 CellTiter-Glo(R) One Solution Assay, 500ml

Group Three - Delivery within 9 months from award date
Item # Quantity Product Description
G8462 20 CellTiter-Glo(R) One Solution Assay, 500ml

The contractor shall provide for any shipping and handling associated with delivering these reagents. Each delivery, together with any associated shipping and handling for the particular delivery, shall be quoted as a separate line item.

Anticipated Contract Type:
A firm fixed price contract is anticipated. Invoicing shall be on a NET30 basis and payment shall be made via Electronic Funds Transfer (EFT).

Period of Performance/Delivery Requirements:
The anticipated contract period of performance is nine (9) months from date of award.
The contractor shall deliver each reagent group based on the dates indicated for each group detailed in the Project Requirements section of this statement of need. Delivery must be FOB Destination. The reagents shall be delivered between the hours of 8:00am and 5:00pm, Rockville, MD local prevailing time, Monday through Friday.

Place of Performance:
All required reagent groups shall be delivered to 9800 Medical Center Drive, Rockville, MD 20850.

Capability Statement:
Contractors that believe they possess the ability to provide the required reagents should submit documentation of their ability to meet each of the project requirements to the Contract Specialist.

The capability statement should include 1) the total number of employees, 2) documentation of ability to provide the required reagents, 3) any contractor GSA Schedule contracts by which all of the requirements may be met, if applicable, and 4) any other information considered relevant to this program. Contractors must also provide their Company Name, DUNS number, Physical Address, and Point of Contact Information.

Interested organizations are required to identify their type of business, applicable North American Industry Classification System Code, and size standards in accordance with the Small Business Administration. The government requests that no proprietary or confidential business data be submitted in a response to this notice. However, responses that indicate the information therein is proprietary will be properly safeguarded for Government use only. Capability statements must include the name and telephone number of a point of contact having authority and knowledge to discuss responses with Government representatives. Capability statements in response to this market survey that do not provide sufficient information for evaluation will be considered non-responsive. When submitting this information, please reference the solicitation notice number.

All capability statements sent in response to this Sources Sought Notice must be submitted to Lauren Phelps, Contract Specialist, via email at [email protected] before the closing date and time of this announcement. All responses must be received by the specified due date and time in order to be considered.

Note:

This notice does not obligate the Government to award a contract or otherwise pay for the information provided in the response. No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After review of the responses received, pre-solicitation and solicitation notices may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation. The solicitation release date is pending. The Government anticipates negotiation of a firm fixed price contract.

Bid Protests Not Available

Similar Past Bids

Location Unknown 22 Jul 2016 at 3 PM
Location Unknown 07 Aug 2018 at 4 PM
Center Kentucky 13 Apr 2017 at 7 PM
Fort gordon Georgia 29 Jul 2016 at 2 PM
Fort gordon Georgia 11 Aug 2016 at 1 PM